Differences in the quantity of DNA found in the urine and saliva of smokers versus nonsmokers: Implications for the timing of epigenetic events

Epigenomics

Volumn 4, Issue 3, 2012, Pages 343-352

  Simkin, Melissa ^a,b   Abdalla, Moemen ^b   El Mogy, Mohamed ^b   Haj Ahmad, Yousef ^a,b  

^a BROCK UNIVERSITY   (Canada)

^b Norgen Biotek Corporation   (Canada)

Author keywords

apoptosis; DNA methylation; p53 protein; saliva; smoking; urine

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BODY FLUID; CANCER GROWTH; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DETERMINATION; DNA ISOLATION; DNA METHYLATION; DNA REPAIR; EPIGENETICS; FEMALE; HUMAN; LUNG BIOPSY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; SALIVA; SMOKING; TP53 GENE; TUMOR SUPPRESSOR GENE; URINE;

ADULT; BIOPSY; CPG ISLANDS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LUNG; MALE; PROMOTER REGIONS, GENETIC; SALIVA; SMOKING; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862256325     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.12.24     Document Type: Article

References (34)

1. Majewski IJ, Bernards R. Taming the dragon: genomic biomarkers to individualize the treatment of cancer. Nat. Med. 17(3), 304-312 (2011). Explains the significance of biomarkers, specifically their impact on the preventative medicine field and the healthcare industry.
2. Maxwell A, McCudden CR, Wians F, Willis MS. Recent advances in the detection of prostate cancer using epigenetic markers in commonly collected laboratory samples. Lab. Med. 40(3), 171-178 (2009).
3. Movassagh M, Choy MK, Knowles DA et al. Distinct epigenomic features in end-stage failing human hearts. Circulation 124(22), 2411-2422 (2011).
4. Maunakea AK, Chepelev I, Zhao K. Epigenome mapping in normal and disease states. Circ. Res. 107, 327-339 (2010).
5. Laurent L, Wong E, Li G et al. Dynamic changes in the human methylome during differentiation. Genome Res. 20, 320-331 (2010).
6. Vaissiere T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mut. Res. 659, 40-48 (2008).
7. Kerr KM, Gallerb JS, Hagenc JA, Laird PW, Laird-Offringab IA. The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis. Markers. 23, 5-30 (2007). An excellent summary of the work done up until 2007 on the role of DNA methylation on lung cancer, including the use of urine and saliva as biological samples for methylation analyses.
8. Sánchez-Abarca L I, Gutierrez-Cosio S, Santamaría C et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood 115(1), 107-121 (2011).
9. Brady CA, Attardi LD. P53 at a glance. J. Cell. Sci. 123, 2527-2532 (2010).
10. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J. Canc. Res. Clin. Oncol. 133, 613-617 (2007).
11. Vlkova B, Szemes T, Minarik G, Turna J, Celec P. Does maternal saliva contain fetal DNA usable for prenatal diagnostics? Med. Hypoth. 74, 258-260 (2010).
12. Beermann A, Ghanjati F, Hermanns T et al. Methods for separate isolation of cell-free DNA and cellular DNA from urine-application of methylation-specific PCR on both DNA fractions. Open Biomark. J. 4, 15-17 (2011).
13. Bryzgunova OE, Skvortsova TE, Kolesnikova EV et al. Isolation and comparative study of cell-free nucleic acids from human urine. Ann. NY Acad. Sci. 1075, 334-340 (2006).
14. Miranda K, Bond D, McKee M et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 78(2), 191-199 (2010).
15. Payne SR, Serth J, Schostak M et al. DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection. Prostate 69, 1257-1269 (2009).
16. Aggarwal BB, Danda D, Gupta S, Gehlot P. Models for prevention and treatment of cancer: problems vs promises. Biochem. Pharmacol. 78, 1083-1094 (2009).
17. Ferguson DB. Saliva as a diagnostic fluid. Acta Stomatol. Croat. 43(2), 77-82 (2009).
18. Cooke MS, Henderson PT, Evans MD. Sources of extracellular, oxidatively modified DNA lesions: implications for their measurement in urine. J. Clin. Biochem. Nutr. 45, 255-270 (2009).
19. Murray K, Walker C, Herrington E et al. Persistent Infection with West Nile Virus Years after Initial Infection. J. Infect. Dis. 201(1), 2-4. (2010).
20. Kuralaya F, Campuzanoa S, Haake DA, Wanga J. Highly sensitive disposable nucleic acid biosensors for direct bioelectronic detection in raw biological samples. Talanta 85, 1330-1337 (2011).
21. Holdenrieder S, Stieber P. Clinical use of circulating nucleosomes. Crit. Rev. Clin. Lab. Sci. 46(1), 1-24 (2009).
22. Serrano A, Castro-Vega I, Redondo M. Role of gene methylation in antitumor immune response: implication for tumor progression. Cancers 3, 1672-1690 (2011). Outlines the effect of epigenetic alterations on immune system response, and discusses the role of age on immune system epigenetic change recognition.
23. Iacobuzio-Donahue CA. Epigenetic changes in cancer. Annu. Rev. Pathol. Mech. Dis. 4, 229-249 (2009).
24. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp. Gerontol. 43(8), 718-728 (2008).
25. Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, van Damme P. Detection of human papillomavirus DNA in urine: a review of the literature. Eur. J. Clin. Microbiol. 31(5), 627-640 (2011).
26. Zhang S, Zhao S, Zhu R, Zhang G, Li C. UTI preventing DNA degradation of storing urinary samples for genotyping. Forensic Sci. Int. Gen. 3, e3-e4 (2011).
27. American Cancer Society: Global Cancer Facts and Figures (2nd Edition). Atlanta, GA, USA. www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-027766.pdf
28. Norgen Biotek Corporation Saliva DNA Collection, Preservation and Isolation Kit: product insert. Thorold, ON, Canada (2012). www.norgenbiotek.com/ product-resources/saliva-dna-collection-preservation-and-isolation-kit-saliva- dna-collection-preservation-and-isolation-kit-protocol-35700-1649.pdf
29. Norgen Biotek Corporation Urine DNA Concentration, Preservation and Isolation Kit: product insert. Thorold, ON, Canada (2012).www.norgenbiotek.com/ product-resources/urine-dna-concentration-preservation-and-isolation-kit-urine- dna-concentration-preservation-and-isolation-kit-protocol-10-preps-38000-1173. pdf
30. Norgen Biotek Corporation Saliva DNA Isolation Kit: product insert. Thorold, ON (2012). www.norgenbiotek.com/product-resources/saliva-dna-isolation- kit-saliva-dna-isolation-kit-protocol-45400-1635.pdf
31. Norgen Biotek Corporation FastRunner DNA Ladder: product insert. Thorold, ON, Canada (2012). www.norgenbiotek.com/product-resources/fastrunner-dna- ladder-fastrunner-dna-ladder-product-insert-12800-120.pdf
32. Norgen Biotek Corporation MidRanger 1kb DNA Ladder: product insert. Thorold, ON (2012). www.norgenbiotek.com/product-resources/midranger-1-kb-dna- ladder-midranger-1kb-dna-ladder-product-insert-11700-136.pdf
33. Norgen Biotek Corporation UltraRanger 1kb DNA Ladder: product insert. www.norgenbiotek.com/product-resources/ultraranger-1-kb-dna-ladder-ultraranger- 1kb-dna-ladder-product-insert-12100-137.pdf
34. Norgen Biotek Corporation Oligo Clean-Up and Concentration Kit: product insert. Thorold, ON, Canada (2012). www.norgenbiotek.com/product-resources/ oligo-cleanup-and-concentration-kit-oligo-cleanup-and-concentration-kit- protocol-34100-1485.pdf